Trial intelligence / Profile preview

REVEAL anacetrapib outcomes trial

2010-023467-18Phase 3Unknown

Sponsor
University of Oxford
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in atherosclerotic disease comparing Anacetrapib arm with Placebo arm (2 arms). Primary endpoint: Major coronary events. Status: unknown.

02

Drugs

anacetrapib
03

Conditions

atherosclerotic disease

Beyond the preview

Go deeper on 2010-023467-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023467-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call